Arkolith/Insider Trading/TALS/Form 4

Ildstad Suzanne

Chief Scientific OfficerTalaris Therapeutics, Inc. (TALS) · full profile →Form 4 · filed Feb 2, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2021Gift(G)1.2M—$03.6M
Nov 17, 2021Gift(G)1.2M—$01.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 1, 2022Grant(A)150K—$0150K

Transaction Codes

G
Gift
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-004205) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML